
Sanjiv J. Shah
Professor, Feinberg School of Medicine · Feinberg School of Medicine
Credentials: · · · ·
History
Present
- Until 2007
- Until 2006
University of California
- Until 2003
University of California

Research
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
New England Journal of Medicine · 2022 · 2,297 citations
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
New England Journal of Medicine · 2018 · 2,246 citations
Spironolactone for heart failure with preserved ejection fraction
New England Journal of Medicine · 2014 · 2,220 citations
- SS
204 papers

140 papers · 18 as a resident
- AD
138 papers
- BP
98 papers

88 papers
- MK
84 papers

63 papers

59 papers
Grants
- 2021–2027
National Heart, Lung, and Blood Institute · U54
Contact PI · $19M · Northwestern University
- 2024–2027
SysBio FAIRplex: A FAIR PLatform for EXploration of Systems Biology
NIH Office of the Director · OT2
PI · $9.2M · Verily Life Sciences Llc
- 2026–2027
National Heart, Lung, and Blood Institute · UG3
PI · $1.3M · Ihc Health Services, Inc.
- 2019–2025
National Heart, Lung, and Blood Institute · R01
PI · $1.6M · Ohio State University
Clinical trials
- 2024–2026
Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
Principal investigator · Recruiting
Northwestern University
- 2024–2028
NOrthwestern Tempus AI-enaBLed Electrocardiography (NOTABLE) Trial
Principal investigator · Recruiting
Northwestern University
- 2023–2026
Principal investigator · Recruiting
Northwestern University
- 2022–2031



